Table 4.
30-d mortality (%p) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total |
Male |
Female |
||||||||||
Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | ||||
Treatment effect | 0.998 (0.391)* | 0.273 (0.377) | -0.087 (0.408) | 1.206 (0.403)** | 0.585 (0.473) | 0.397 (0.606) | 0.753 (0.819) | -0.924 (0.701) | -1.388 (0.884) | |||
Time trend1 | ||||||||||||
2008 | 0.731 (0.243)** | 0.726 (0.289)* | 0.723 (0.333)* | 0.745 (0.403)† | 0.736 (0.642) | 0.500 (0.796) | ||||||
2009 | 0.217 (0.273) | 0.917 (0.610) | 0.223 (0.318) | 0.905 (0.853) | 0.509 (0.821) | 1.730 (1.168) | ||||||
2010 | 1.086 (0.413)* | 2.361 (0.824)* | 0.612 (0.316)† | 1.664 (1.065) | 3.150 (0.886)** | 4.719 (1.655)* | ||||||
2011 | 0.808 (0.350)* | 1.847 (0.514)** | 1.365 (0.362)** | 2.046 (0.840)* | 2.074 (0.918)* | 4.001 (1.469)* | ||||||
2012 | 0.635 (0.224)* | 1.726 (0.854)† | 0.332 (0.286) | 1.555 (1.253) | 2.027 (0.693)* | 2.668 (1.493)† | ||||||
2013 | 0.981 (0.471)† | 2.243 (0.690)** | 1.176 (0.510)* | 2.405 (1.110)* | 1.231 (1.088) | 2.424 (1.572) | ||||||
2014 | 1.415 (0.445)** | 2.524 (0.887)* | 1.171 (0.356)** | 2.024 (1.245) | 2.366 (1.194)† | 3.534 (2.175) | ||||||
2015 | 1.357 (0.461)* | 2.824 (1.104)* | 0.945 (0.424)* | 1.956 (1.459) | 3.605 (1.063)** | 5.232 (2.252)* | ||||||
2016 | 1.616 (0.531)** | 2.894 (1.328)* | 1.494 (0.431)** | 2.334 (1.613) | 2.438 (1.113)* | 3.862 (2.407) | ||||||
Covariates | ||||||||||||
No. of medical facilities | ||||||||||||
Tertiary hospital | 0.059 (0.211) | 0.036 (0.178) | 0.288 (0.501) | |||||||||
Secondary hospital | 0.170 (0.123) | 0.219 (0.154) | 0.147 (0.171) | |||||||||
Clinic | 0.004 (0.004) | 0.008 (0.005) | -0.003 (0.006) | |||||||||
No. of medical personnel | ||||||||||||
Internal medicine | 0.002 (0.003) | -0.001 (0.004) | 0.005 (0.006) | |||||||||
Emergency medicine | -0.040 (0.019)† | -0.043 (0.029) | -0.027 (0.047) | |||||||||
General practitioners | -0.001 (0.001) | -0.000 (0.001) | 0.000 (0.001) | |||||||||
Population aged >65 (%) | 0.046 (0.335) | -0.027 (0.379) | 0.136 (0.467) | |||||||||
GRDP per capita (million Korean won) | 0.060 (0.039) | 0.038 (0.044) | 0.155 (0.047)** | |||||||||
Health-related behavior (%) | ||||||||||||
High-risk alcohol consumption | 0.060 (0.130) | 0.136 (0.146) | -0.223 (0.216) | |||||||||
Prevalence of hypertension | -0.298 (0.096)** | -0.219 (0.160) | -0.761 (0.304)* | |||||||||
Control rate of hypertension | 0.153 (0.124) | 0.070 (0.162) | 0.551 (0.202)* | |||||||||
Prevalence of diabetes | 0.310 (0.259) | 0.390 (0.370) | 0.701 (0.748) | |||||||||
Control rate of diabetes | -0.026 (0.034) | -0.042 (0.042) | -0.150 (0.068)* | |||||||||
Prevalence of perceived obesity | 0.129 (0.080) | 0.061 (0.076) | 0.358 (0.152)* | |||||||||
Prevalence of perceived stress | 0.039 (0.062) | 0.042 (0.089) | 0.012 (0.125) | |||||||||
Prevalence of smoking | 0.213 (0.154) | 0.099 (0.205) | 0.306 (0.493) | |||||||||
Constant | 4.418 (0.201)** | 3.906 (0.331)** | -28.460 (11.990)* | 3.684 (0.207)** | 3.199 (0.260)** | -23.420 (15.760) | 7.838 (0.420)** | 6.886 (0.822)** | -43.320 (25.540) | |||
Within R2 | 0.111 | 0.246 | 0.401 | 0.118 | 0.225 | 0.340 | 0.014 | 0.169 | 0.306 |
Robust standard errors in parentheses.
RCCVC, regional Cardiocerebrovascular Center; GRDP, gross regional domestic product.
Year 2007 as reference.
p<0.1,
p<0.05,
p<0.01.